126 related articles for article (PubMed ID: 38105209)
1. Effects of Progesterone and Selective Ligands of Membrane Progesterone Receptors in HepG2 Cells of Human Hepatocellular Carcinoma.
Shchelkunova TA; Levina IS; Morozov IA; Rubtsov PM; Goncharov AI; Kuznetsov YV; Zavarzin IV; Smirnova OV
Biochemistry (Mosc); 2023 Nov; 88(11):1920-1932. PubMed ID: 38105209
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic Effects of the Selective Ligands of Membrane Progesterone Receptors in Human Pancreatic Adenocarcinoma Cells BxPC3.
Goncharov AI; Levina IS; Shliapina VL; Morozov IA; Rubtsov PM; Zavarzin IV; Smirnova OV; Shchelkunova TA
Biochemistry (Mosc); 2021 Nov; 86(11):1446-1460. PubMed ID: 34906046
[TBL] [Abstract][Full Text] [Related]
3. Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.
Charles NJ; Thomas P; Lange CA
Horm Cancer; 2010 Aug; 1(4):167-76. PubMed ID: 21761364
[TBL] [Abstract][Full Text] [Related]
4. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
5. Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors.
Dressing GE; Alyea R; Pang Y; Thomas P
Horm Cancer; 2012 Jun; 3(3):101-12. PubMed ID: 22350867
[TBL] [Abstract][Full Text] [Related]
6. Selective ligands of membrane progesterone receptors as a key to studying their biological functions in vitro and in vivo.
Levina IS; Kuznetsov YV; Shchelkunova TA; Zavarzin IV
J Steroid Biochem Mol Biol; 2021 Mar; 207():105827. PubMed ID: 33497793
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effects of progesterone and selective ligands of membrane progesterone receptors.
Polikarpova AV; Levina IS; Sigai NV; Zavarzin IV; Morozov IA; Rubtsov PM; Guseva AA; Smirnova OV; Shchelkunova TA
Steroids; 2019 May; 145():5-18. PubMed ID: 30753845
[TBL] [Abstract][Full Text] [Related]
8. Cell-surface expression, progestin binding, and rapid nongenomic signaling of zebrafish membrane progestin receptors alpha and beta in transfected cells.
Hanna R; Pang Y; Thomas P; Zhu Y
J Endocrinol; 2006 Aug; 190(2):247-60. PubMed ID: 16899559
[TBL] [Abstract][Full Text] [Related]
9. Progesterone increases epirubicin's apoptotic effects in HepG2 cells by S phase cell cycle arrest.
Chang WT; Lin HL; Chang KL; Ker CG; Huang MC; Chen JS; Kuo KK; Chen YL; Lee KT
Hepatogastroenterology; 2010; 57(97):107-13. PubMed ID: 20422883
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions.
Thomas P
Front Neuroendocrinol; 2008 May; 29(2):292-312. PubMed ID: 18343488
[TBL] [Abstract][Full Text] [Related]
11. Progesterone inhibits proliferation and modulates expression of proliferation-Related genes in classical progesterone receptor-negative human BxPC3 pancreatic adenocarcinoma cells.
Goncharov AI; Maslakova AA; Polikarpova AV; Bulanova EA; Guseva AA; Morozov IA; Rubtsov PM; Smirnova OV; Shchelkunova TA
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):293-304. PubMed ID: 27449817
[TBL] [Abstract][Full Text] [Related]
12. Expression of nuclear progesterone receptors (nPRs), membrane progesterone receptors (mPRs) and progesterone receptor membrane components (PGRMCs) in the human endometrium after 6 months levonorgestrel low dose intrauterine therapy.
Sletten ET; Smaglyukova N; Ørbo A; Sager G
J Steroid Biochem Mol Biol; 2020 Sep; 202():105701. PubMed ID: 32479983
[TBL] [Abstract][Full Text] [Related]
13. Human homologs of the putative G protein-coupled membrane progestin receptors (mPRalpha, beta, and gamma) localize to the endoplasmic reticulum and are not activated by progesterone.
Krietsch T; Fernandes MS; Kero J; Lösel R; Heyens M; Lam EW; Huhtaniemi I; Brosens JJ; Gellersen B
Mol Endocrinol; 2006 Dec; 20(12):3146-64. PubMed ID: 16959873
[TBL] [Abstract][Full Text] [Related]
14. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
[TBL] [Abstract][Full Text] [Related]
15. Membrane progesterone receptors β and γ have potential as prognostic biomarkers of endometrial cancer.
Sinreih M; Knific T; Thomas P; Frković Grazio S; Rižner TL
J Steroid Biochem Mol Biol; 2018 Apr; 178():303-311. PubMed ID: 29353001
[TBL] [Abstract][Full Text] [Related]
16. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term.
Karteris E; Zervou S; Pang Y; Dong J; Hillhouse EW; Randeva HS; Thomas P
Mol Endocrinol; 2006 Jul; 20(7):1519-34. PubMed ID: 16484338
[TBL] [Abstract][Full Text] [Related]
17. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
[TBL] [Abstract][Full Text] [Related]
18. Expression of membrane progestin receptors (mPRs) α, β and γ in the bovine uterus during the oestrous cycle and pregnancy.
Kowalik MK; Dobrzyn K; Rekawiecki R; Kotwica J
Theriogenology; 2019 Dec; 140():171-179. PubMed ID: 31479833
[TBL] [Abstract][Full Text] [Related]
19. [Effect and mechanism of liraglutide on the apoptosis of human hepatocellular carcinoma HepG2 cells induced with palmitic acid].
Ao N; Yang J; Du J
Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):445-449. PubMed ID: 31357761
[No Abstract] [Full Text] [Related]
20. Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway.
Li L; Zheng BB; Ma LS; Sun X; Chang JJ; Xie WD; Li X
Acta Pharmacol Sin; 2014 Oct; 35(10):1311-22. PubMed ID: 25176399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
